Corpus Intelligence IC Memo — ST ELIZABETH FT THOMAS 2026-04-26 06:49 UTC
IC Memo — ST ELIZABETH FT THOMAS
Investment Committee Memorandum | KY | 128 beds | Grade C | EBITDA uplift $9.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST ELIZABETH FT THOMAS

CCN 180001 | CAMPBELL, KY | 128 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ST ELIZABETH FT THOMAS is a 128-bed suburban community hospital in CAMPBELL, KY with $124.3M in net patient revenue and a -9.6% operating margin. The hospital serves a payer mix of 27.4% Medicare, 1.1% Medicaid, and 71.5% commercial.

Thesis: Undervalued. Our ML models identify $9.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.6% to -2.2% (+736bps).

Net Revenue HCRIS$124.3M
Current EBITDA COMPUTED$-11.9M
Operating Margin COMPUTED-9.6%
Occupancy HCRIS62.2%
Revenue / Bed COMPUTED$971K
Net-to-Gross HCRIS30.9%
Distress Probability ML45.1%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
40
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -9.6% places it below the state median. Among 40 size-comparable peers (64-256 beds), the median margin is 2.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (64-256), prioritizing same-state peers. 40 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST ELIZABETH FT THOMAS (Target)KY128$124.3M-9.6%
BAPTIST HEALTH PADUCAHKY190$391.7M-0.5%
SAINT JOSEPH HOSPITALKY252$322.8M-17.3%
MERCY HEALTH LOURDES HOSPITAL KY178$288.1M7.7%
BAPTIST HEALTH CORBINKY197$285.4M1.4%
LAKE CUMBERLAND REGIONAL HOSPKY179$278.7M5.6%
BAPTIST HEALTH MADISONVILLEKY154$220.0M-5.7%
ST. ELIZABETH FLORENCEKY134$212.6M8.8%
SAINT JOSEPH EASTKY138$209.5M2.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.6M+210bp18mo
Cost to Collect4.5%2.5%$2.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$80K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.6M
Cost to Collect
$2.5M
Denial Rate Reduction
$2.5M
A/R Days Reduction
$1.5M
Clean Claim Rate
$80K
Total EBITDA Uplift$9.1M
Current EBITDA$-11.9M
+ RCM Uplift+$9.1M
Pro Forma EBITDA$-2.8M
Current Margin-9.6%
Pro Forma Margin-2.2%
WC Released (1x)$4.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-18.3M$12.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-18.3M$8.3M0.00x-100.0%
Bull Case9.0x11.0x$-16.5M$32.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-16.5M$30.6M0.00x-100.0%
Bear Case11.0x10.0x$-20.1M$-26.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-20.1M$-36.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 40 hospitals with 64-256 beds
  • Same-state prioritization (n=41)
  • Comp margins: P25=-9.0% / P50=2.0% / P75=11.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.